MALATHION

MALATHION was reported 101 times

MALATHION is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VENTOUSE EXTRACTION 2 0.0541
1 PREGNANCY WITH INJECTABLE CONTRACEPTIVE 7 0.0329
2 PRODUCT CONTAMINATION CHEMICAL 3 0.0138
3 CAUSTIC INJURY 4 0.0128
4 CHEMICAL POISONING 4 0.0107
5 SUBENDOCARDIAL ISCHAEMIA 1 0.0090
6 CHEMICAL INJURY 4 0.0049
7 LICE INFESTATION 1 0.0048
8 EXPOSURE VIA INHALATION 1 0.0046
9 SOMATIC DELUSION 1 0.0041
10 INFESTATION 1 0.0039
11 BURNS SECOND DEGREE 5 0.0028
12 INSTILLATION SITE ERYTHEMA 1 0.0019
13 APPLICATION SITE SCAB 4 0.0019
14 AURICULAR SWELLING 1 0.0017
15 CHOLINERGIC SYNDROME 1 0.0016
16 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
17 APPLICATION SITE ULCER 1 0.0014
18 EXPOSURE VIA DIRECT CONTACT 1 0.0011
19 ELECTROCARDIOGRAM CHANGE 1 0.0011
20 PARTNER STRESS 1 0.0010
21 THERMAL BURN 7 0.0010
22 HYPOPERFUSION 1 0.0010
23 ACARODERMATITIS 1 0.0009
24 APPLICATION SITE BURN 4 0.0008
25 APPLICATION SITE PARAESTHESIA 1 0.0008
26 TOBACCO USER 1 0.0007
27 APPLICATION SITE VESICLES 4 0.0006
28 DEMENTIA ALZHEIMER'S TYPE 1 0.0006
29 BLOOD AMYLASE INCREASED 1 0.0006
30 ALOPECIA AREATA 1 0.0006
31 SKIN HYPOPIGMENTATION 1 0.0006
32 PURULENCE 1 0.0005
33 APPLICATION SITE EXFOLIATION 2 0.0005
34 ACCIDENTAL EXPOSURE 2 0.0005
35 DANDRUFF 1 0.0005
36 CHEMICAL BURN OF SKIN 1 0.0004
37 VENTRICULAR DYSFUNCTION 1 0.0004
38 RHINALGIA 1 0.0004
39 ACUTE PULMONARY OEDEMA 2 0.0004
40 SCREAMING 2 0.0003
41 EXPOSURE TO TOXIC AGENT 1 0.0003
42 APPLICATION SITE REACTION 2 0.0003
43 FRUSTRATION 1 0.0003
44 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
45 HYPERPHAGIA 1 0.0003
46 MIOSIS 2 0.0002
47 LIVE BIRTH 2 0.0002
48 POISONING 3 0.0002
49 ISCHAEMIA 1 0.0002
50 NEPHROGENIC ANAEMIA 1 0.0002
51 DRUG EXPOSURE DURING PREGNANCY 7 0.0002
52 MULTIPLE DRUG OVERDOSE 1 0.0002
53 FEMORAL NECK FRACTURE 1 0.0002
54 STOMACH DISCOMFORT 1 0.0002
55 PRODUCT ODOUR ABNORMAL 2 0.0002
56 POOR QUALITY PRODUCT ADMINISTERED 2 0.0002
57 PERONEAL NERVE PALSY 1 0.0002
58 DERMATITIS CONTACT 2 0.0002
59 RALES 1 0.0002
60 PLEURISY 1 0.0002
61 DERMATITIS ACNEIFORM 1 0.0002
62 OLIGURIA 1 0.0002
63 APPLICATION SITE IRRITATION 2 0.0002
64 PRODUCT LABEL ISSUE 1 0.0001
65 DRUG TOXICITY 2 0.0001
66 RESPIRATION ABNORMAL 1 0.0001
67 DROOLING 1 0.0001
68 CARDIOGENIC SHOCK 2 0.0001
69 RASH PUSTULAR 1 0.0001
70 APPLICATION SITE PAIN 3 0.0001
71 TROPONIN INCREASED 1 0.0001
72 ACIDOSIS 1 0.0001
73 APNOEA 1 0.0001
74 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
75 NASAL DISCOMFORT 1 0.0001
76 POLYURIA 1 0.0001
77 HYPERAESTHESIA 1 0.0001
78 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
79 VITAMIN D DECREASED 1 0.0001
80 APPLICATION SITE ERYTHEMA 3 0.0001
81 CARDIOTOXICITY 1 0.0001
82 RENAL TUBULAR NECROSIS 1 0.0001
83 UNINTENDED PREGNANCY 1 0.0001
84 VENTRICULAR FIBRILLATION 1 0.0001
85 SKIN DISORDER 3 0.0001
86 SKIN INFECTION 1 0.0001
87 ANGER 3 0.0001
88 SCAB 1 0.0001
89 MADAROSIS 1 0.0001
90 ELECTROLYTE IMBALANCE 1 0.0001
91 NO THERAPEUTIC RESPONSE 1 0.0001
92 CARDIOMEGALY 1 0.0001
93 MUSCLE ATROPHY 1 0.0001
94 ANOREXIA 1 0.0001
95 PHARMACEUTICAL PRODUCT COMPLAINT 2 0.0001
96 TACHYPNOEA 1 0.0001
97 PERIPHERAL COLDNESS 1 0.0001
98 MASS 1 0.0001
99 BLISTER 4 0.0001
100 BLINDNESS UNILATERAL 1 0.0001
101 SINUS TACHYCARDIA 1 0.0001
102 IMPAIRED QUALITY OF LIFE 1 0.0001
103 CARDIOMYOPATHY 1 0.0001
104 BLOOD POTASSIUM DECREASED 2 0.0001
105 LACRIMATION INCREASED 2 0.0001
106 CYANOSIS 1 0.0001
107 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
108 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
109 EXPIRED PRODUCT ADMINISTERED 2 0.0001
110 BLOOD UREA INCREASED 1 0.0001
111 PERICARDITIS 1 0.0001
112 SCAR 1 0.0001
113 BURNING SENSATION 4 0.0001
114 LEUKOCYTOSIS 1 0.0001
115 CRYING 2 0.0001
116 END STAGE RENAL DISEASE 1 0.0001
117 CONJUNCTIVITIS 1 0.0001
118 BACTERIAL INFECTION 1 0.0001
119 HALLUCINATION 4 0.0001
120 BLOOD SODIUM DECREASED 1 0.0001
121 CONVULSION 3 0.0001
122 EAR PAIN 1 0.0001
123 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
124 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
125 HAEMATOCRIT DECREASED 1 0.0001
126 BODY TEMPERATURE INCREASED 1 0.0000
127 DERMATITIS 1 0.0000
128 ALOPECIA 9 0.0000
129 MUSCLE TWITCHING 1 0.0000
130 OCULAR HYPERAEMIA 2 0.0000
131 COMA 2 0.0000
132 EPISTAXIS 3 0.0000
133 AGGRESSION 2 0.0000
134 CHRONIC KIDNEY DISEASE 3 0.0000
135 RASH GENERALISED 1 0.0000
136 ANHEDONIA 1 0.0000
137 PAIN OF SKIN 1 0.0000
138 THROAT TIGHTNESS 1 0.0000
139 PALLOR 1 0.0000
140 RESPIRATORY DISTRESS 1 0.0000
141 FEELING COLD 1 0.0000
142 LETHARGY 2 0.0000
143 EYE IRRITATION 2 0.0000
144 DYSSTASIA 1 0.0000
145 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
146 DRUG ADMINISTRATION ERROR 1 0.0000
147 BONE DENSITY DECREASED 1 0.0000
148 METABOLIC ACIDOSIS 1 0.0000
149 LIP SWELLING 1 0.0000
150 GAIT INABILITY 1 0.0000
151 HYPERKALAEMIA 1 0.0000
152 HYPOXIA 1 0.0000
153 LYMPHADENOPATHY 1 0.0000
154 SKIN BURNING SENSATION 2 0.0000
155 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
156 EYE SWELLING 1 0.0000
157 ASTHMA 3 0.0000
158 ABNORMAL BEHAVIOUR 1 0.0000
159 EMOTIONAL DISTRESS 3 0.0000
160 OSTEOPOROSIS 1 0.0000
161 RHABDOMYOLYSIS 1 0.0000
162 SKIN EXFOLIATION 2 0.0000
163 THERAPY NON-RESPONDER 1 0.0000
164 SKIN IRRITATION 1 0.0000
165 SKIN DISCOLOURATION 1 0.0000
166 SWELLING 2 0.0000
167 DISEASE RECURRENCE 1 0.0000
168 HEART RATE INCREASED 2 0.0000
169 BRADYCARDIA 1 0.0000
170 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
171 DRUG EFFECT DECREASED 1 0.0000
172 DISTURBANCE IN ATTENTION 1 0.0000
173 RASH PRURITIC 1 0.0000
174 PAIN 11 0.0000
175 ABDOMINAL PAIN 4 0.0000
176 NASAL CONGESTION 1 0.0000
177 VOMITING 8 0.0000
178 SUICIDE ATTEMPT 1 0.0000
179 STOMATITIS 1 0.0000
180 PLEURAL EFFUSION 1 0.0000
181 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
182 LOSS OF CONSCIOUSNESS 2 0.0000
183 HYPERHIDROSIS 2 0.0000
184 AMNESIA 1 0.0000
185 BLOOD CREATININE INCREASED 1 0.0000
186 RENAL FAILURE 2 0.0000
187 BLOOD PRESSURE DECREASED 1 0.0000
188 SLEEP DISORDER 1 0.0000
189 OVERDOSE 3 0.0000
190 INFECTION 2 0.0000
191 AGITATION 1 0.0000
192 DYSGEUSIA 1 0.0000
193 HYPOAESTHESIA 2 0.0000
194 BLOOD PRESSURE INCREASED 2 0.0000
195 CARDIAC FAILURE CONGESTIVE 1 0.0000
196 DYSPNOEA 7 0.0000
197 CARDIAC ARREST 1 0.0000
198 TREMOR 2 0.0000
199 TOXICITY TO VARIOUS AGENTS 2 0.0000
200 MYOCARDIAL INFARCTION 2 0.0000
201 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
202 TACHYCARDIA 1 0.0000
203 GASTROINTESTINAL DISORDER 1 0.0000
204 SUICIDAL IDEATION 1 0.0000
205 MUSCLE SPASMS 2 0.0000
206 OROPHARYNGEAL PAIN 1 0.0000
207 CHEST PAIN 2 0.0000
208 CARDIAC DISORDER 1 0.0000
209 ANXIETY 3 0.0000
210 GAIT DISTURBANCE 2 0.0000
211 HAEMOGLOBIN DECREASED 1 0.0000
212 ERYTHEMA 2 0.0000
213 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
214 DRUG INEFFECTIVE 12 0.0000
215 INFLUENZA 1 0.0000
216 INCORRECT DOSE ADMINISTERED 2 0.0000
217 SEIZURE 1 0.0000
218 OEDEMA PERIPHERAL 1 0.0000
219 DIARRHOEA 5 0.0000
220 DRY SKIN 1 0.0000
221 PAIN IN EXTREMITY 2 0.0000
222 ACUTE KIDNEY INJURY 1 0.0000
223 DRUG INTERACTION 1 0.0000
224 DRUG DEPENDENCE 1 0.0000
225 COVID-19 1 0.0000
226 HYPERSENSITIVITY 1 0.0000
227 PRURITUS 2 0.0000
228 NAUSEA 4 0.0000
229 HYPOTENSION 1 0.0000
230 SOMNOLENCE 1 0.0000
231 ARTHRALGIA 2 0.0000
232 RASH 2 0.0000
233 MALAISE 2 0.0000
234 WEIGHT INCREASED 1 0.0000
235 DEPRESSION 1 0.0000
236 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
237 FATIGUE 3 0.0000
238 COUGH 1 0.0000
239 OFF LABEL USE 3 0.0000
240 CONDITION AGGRAVATED 1 0.0000
241 PNEUMONIA 1 0.0000
242 FALL 1 0.0000
243 PYREXIA 1 0.0000
244 DIZZINESS 1 0.0000
245 HEADACHE 1 0.0000